First, despite the majority of published studies illustrating that the PD-1/PD-L1 axis serves a profibrotic role in IPF and pharmaceutical intervention of this pathway could alleviate pulmonary fibrosis, all results were obtained based on murine studies, and the evidence from clinical studies remains lacking. The gene discussed is RPL17; the disease is pulmonary fibrosis.